Since the COVID-19 infection flare-up in December 2019, the malady has spread to right around 100 nations around the world with the World Health Organization proclaiming it a general wellbeing crisis. The worldwide effects of the coronavirus sickness 2019 (COVID-19) are now beginning to be felt, and will essentially influence the Healthcare Industry in 2020.
The rising incidence of HIV, growing applications of western blotting technique in the field of proteomics and the growing expenditure on research and development by various pharmaceutical and biotechnology companies are some of the major factors stimulating the growth of the global western blotting market during the forecast period, 2017-2021.
These are some of the findings of the latest comprehensive report which has been released by Persistence Market Research titled as ‘Western Blotting Market: Global Industry Analysis and Forecast 2017-2021’. This report explores the market dynamics affecting the expansion of the global western blotting market in the form of drivers, restraints, opportunities and trends, which are comprehensively studied in this latest report.
Regions Covered In Report
Americas (United States, Canada, Mexico, and Brazil), APAC (China, Japan, Korea, Southeast Asia,India, and Australia), Europe (Germany, France, UK, Italy, Russia, and Spain), and Middle East & Africa (Egypt, South Africa, Israel, Turkey, and GCC Countries).
Get Sample Copy of Report @ https://www.persistencemarketresearch.com/samples/3044
Company Profiles :
- Thermo Fisher Scientific, Inc.
- GE Healthcare.
- Hoffmann-La Roche Ltd.
- Danaher Corporation (Lumigen, Inc.)
- EMD Millipore Corporation.
- Bio-Rad Laboratories, Inc.
- PerkinElmer Inc., LI-COR, Inc.
- Bio-Techne Corporation (ProteinSimple Inc.)
- Advansta, Inc.
Get To Know Methodology of Report @ https://www.persistencemarketresearch.com/methodology/3044
As per the forecast, the global western blotting market was valued at US$ 576.4 Mn in 2017 end and is slated to reach a valuation of US$ 725 Mn in 2021 end, reflecting a CAGR of 5.9% during the period of forecast 2017-2021.
Global Western Blotting Market: Market Dynamics
According to the data provided by UNAIDS, there were approximately 36.7 million people across the global living with HIV/AIDS. Western blot testing method is preferred in detection on HIV as it is greatly accurate in finding HIV antibodies in the blood of patients as compared with other testing techniques like ELISA. The diagnosis of HIV is dependent on the detection of the HIV antibody in blood, by the incorporation of HIV antigens. This kind of antigen-antibody assay is helpful in window period of HIV.
Hence, western blotting testing technique is preferred in the detection of anti-HIV antibody in blood serum sample. In addition, there is an increasing amount of investments in R&D sector in the western blotting market for system automation, antibodies, regent kits and buffers.
Such kind of investments are likely to boost the growth of the global western blotting market. However, the emergence of alternative techniques like the alpha technique, which is much simpler than the western blotting technique may restrain the growth of the global western blotting market.
Access Full Report @ https://www.persistencemarketresearch.com/checkout/3044
Global Western Blotting Market: Segmentation and Forecast
The global western blotting market is segmented on the basis of product, end-use, application and region.
On the basis of product, the reagent kits dominated the market. The reagent kits segment was valued at US$ 350.5 Mn in 2017 end. The transfer membranes segment was valued at US$ 62.3 Mn in 2017 end. Innovative reagents are being used for clear visibility and imaging and to reduce the duration of test process are some of the key factors boosting the growth of the reagents kits segment in the western blotting market.
On the basis of application, the scientific research segment was valued at US$ 215.7 Mn in 2017 end. The food and beverage segment was valued at US$ 60.9 Mn in 2017 end. Scientific research segment is projected to reach US$ 277.0 Mn by 2021, creating a total incremental opportunity of US$ 88.3 Mn over the forecast period.
On the basis of end-use, the diagnostic laboratories segment was valued at US$ 145.7 Mn in 2017 end. Need for continuous monitoring of patients suffering from HIV is expected to fuel demand for western blotting tests over the forecast period.
On the basis of region, the Asia Pacific western blotting market was valued at US$ 129.2 Mn in 2017 end. There is a high potential for the growth of western blotting market in the region of Asia Pacific.
What the report encloses for the readers:
- Critical insights of each segment, including volume growth outlook, and demand & supply pattern.
- A to Z of each player –positives & negatives, current status, future developments – of the global market.
- Detailed information regarding the trends influencing the growth of the global market.
- In-depth assessment on the utilization in the industry.
- Historical data and future growth outlook of the global market.
Explore Extensive Coverage of PMR`s Life Sciences & Transformational Health Landscape
Proton Therapy Market Segmented By Single Room, Multiple Room Set up Type with Head and Neck Cancer, Brain Cancer, Sarcoma Pediatric Cancer, Gastro-intestinal Cancer, Prostate Cancer, Lung Cancer Indication. For More Information
Trauma Fixation Devices Market – global trauma fixation devices market is estimated to represent more than US$ 450 Mn of the total market in 2017 and is estimated to reach little more than US$ 800 Mn by 2025 end, expanding at CAGR of 7.5% over the forecast period of 2017–2025.For More Information
Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.
To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.
Our client success stories feature a range of clients from Fortune 500 companies to fast-growing startups. PMR’s collaborative environment is committed to building industry-specific solutions by transforming data from multiple streams into a strategic asset.
Persistence Market Research
Address – 305 Broadway, 7th FloorNew York City,
NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – firstname.lastname@example.org
Website – https://www.persistencemarketresearch.com